Novel Antimicrobial Discovery

About Bactobio

Bactobio is a private, pre-revenue platform biotechnology company targeting the discovery of novel antimicrobials from uncultured microbes. Its core innovation is a two-part platform combining a Microbial Generation Platform, which uses co-culture strategies, automation, and synthetic biology to grow novel microbial species, with a Discovery Platform that screens these microbes for bioactive compounds against specific pathogens. With a seasoned team and notable advisors, the company aims to address the critical global challenges of antimicrobial resistance and sustainable agriculture by accessing an entirely new frontier of natural product chemistry.

About Bactobio

Bactobio is a private, pre-revenue platform biotechnology company targeting the discovery of novel antimicrobials from uncultured microbes. Its core innovation is a two-part platform combining a Microbial Generation Platform, which uses co-culture strategies, automation, and synthetic biology to grow novel microbial species, with a Discovery Platform that screens these microbes for bioactive compounds against specific pathogens. With a seasoned team and notable advisors, the company aims to address the critical global challenges of antimicrobial resistance and sustainable agriculture by accessing an entirely new frontier of natural product chemistry.

Therapeutic Areas